MedTrace Logo

Implementing Low-dose ct Lung Cancer Screening in France.

NCT07513818 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20000

Last updated 2026-05-20

No results posted yet for this study

Summary

The main objective is to estimate the detection rate of lung cancer in the population screened by low-dose chest CT scans.

Conditions

Interventions

PROCEDURE

Low-dose computed tomography of the chest

Baseline low-dose CT acquisition, then at 1 year and 3 years to depict suspicious lung nodules

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Marie-Pierre REVEL, PhD · Assistance Publique - Hôpitaux de Paris

  • Sébastien COURAUD, PhD · Hospices Civils de Lyon

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2031-06-30
Completion
2031-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07513818 on ClinicalTrials.gov